Labs / ADME, DMPK & toxicology

Aclairo Pharmaceutical Development Group, Inc.
Sterling, VA, United States · aclairo.com
Aclairo Pharmaceutical Development Group, Inc. provides nonclinical development and clinical pharmacology consulting for pharmaceutical and biotech clients. It serves programs in human therapeutics from Sterling, Virginia, with support across drug development strategy, DMPK/TK, toxicology, regulatory writing, and clinical pharmacology.
Their website has a general contact form; we send your quote request through it.
What they offer
Cell and Gene Therapy Consulting
Provides strategic advice, program support, study design, and regulatory writing for cell and gene therapy programs, including viral vectors, gene editing, and cell therapies.
Clinical Pharmacology Consulting
Supports pharmacokinetic, pharmacodynamic, dose selection, exposure-response, drug interaction, and special population assessments for regulatory submissions.
Nonclinical DMPK and Toxicokinetics Consulting
Provides ADME, PK/TK analysis, exposure-toxicity assessment, dose justification, and human dose projection support.
Nonclinical Drug Development Operations
Supports planning, vendor selection, CRO oversight, study monitoring, data review, and reporting for nonclinical studies.
Nonclinical Drug Development Strategy
Provides guidance on overall nonclinical development planning and strategy for drug and biologics programs.
Nonclinical Pharmacology
Advises on nonclinical pharmacology program planning and interpretation to support development decisions.
Toxicology Consulting
Provides toxicology expertise for nonclinical development, study interpretation, and regulatory support.
Scientific and Regulatory Writing
Prepares briefing documents, investigator brochures, expert reports, final study reports, and regulatory submissions.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Peptide, Oligonucleotide, Viral vector, Cell therapy, Gene editing, LNP / formulation
- Assays and studies
- ADME, PK, TK, PK/PD, bioanalysis, dose selection, exposure-response, drug interaction, special population assessment, toxicology study monitoring
- Therapeutic areas
- neurology, immunology, oncology, urology, anti-infectives, genetic disorders, cardiovascular, metabolic disorders, women’s health, rare diseases
- Type
- CRO
- Sites
- Sterling, United States
- Team
- over 350 years of combined drug development experience
- Serves
- United States, European Union, Australia, New Zealand, United Kingdom, China, Japan
- Address
- 45600 Terminal Drive Sterling, VA 20166
- Founded
- 2004
Similar labs. Genevoyager, Aurigene Pharmaceutical Services, Crystal NAX, Esco Aster
Found in a contract services directory. Listing built from aclairo.com. Work here? Claim this listing.